Natural Capsules subsidiary approves rights issue of 11.16 lakh shares

Natural Biogenex Private Limited, a material unlisted subsidiary of natural capsules , has approved a rights issue of 11,16,766 equity shares of ₹10 each for cash at par. The allotment aggregates to ₹1,11,67,660 and was approved by the board of the subsidiary on July 10, 2026. The rights issue was previously approved by the board on May 27, 2026.

Allotment Details

The board of Natural Biogenex Private Limited approved the allotment of the rights issue shares during its meeting held on July 10, 2026. The shares were issued for cash at par, with the total amount aggregating to ₹1,11,67,660.

Parameter	Details
Entity	Natural Biogenex Private Limited
Number of Shares Allotted	11,16,766
Face Value	₹10 each
Issue Price	Cash at par
Total Allotment Amount	₹1,11,67,660
Board Approval Date	July 10, 2026
Previous Rights Issue Approval	May 27, 2026

The intimation regarding the allotment was submitted to BSE Limited and National Stock Exchange of India Limited under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+2.01%	-5.46%	-8.74%	-24.81%	-34.35%	-41.91%

Natural Capsules Limited confirmed that its promoters and persons acting in concert (PAC) did not create any encumbrance on their shares during the financial year ended March 31, 2026. The disclosure, submitted to BSE Limited and National Stock Exchange of India Limited, covers all promoters and PACs, stating no direct or indirect encumbrances were made other than those previously disclosed. This compliance filing was made under Regulation 30 and 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The filing details the shareholding structure as of March 31, 2026. The promoters and promoter group collectively hold 53,01,248 shares, representing 51.04% of the company's diluted share capital. The disclosure includes individual holdings of 21 named entities, ranging from individuals like Sunil Laxminarayan Mundra to corporate entities such as Tajos Investments Private Limited.

Shareholding Details

The following table outlines the holdings of the promoters and promoter group as of the specified date:

Shareholder	Shares Held	% of Share Capital	% of Diluted Share Capital
Indra Mundra	3,91,800	3.77	3.77
Jyoti Mundra	3,06,694	2.95	2.95
Shrey Mundra	1,65,150	1.59	1.59
Sunil Laxminarayan Mundra	6,02,290	5.80	5.80
Laxminarayan Moondra	2,40,441	2.32	2.32
Radha S Mundra	2,39,400	2.31	2.31
Sushil Kumar Mundra	5,09,012	4.90	4.90
Satyanarayana Mundra	1,84,882	1.78	1.78
Sharda Mundra	2,65,036	2.55	2.55
Jyostna Daga	37,789	0.36	0.36
Madhav Mundra	1,65,155	1.59	1.59
Nidhi Sethia	18,484	0.18	0.18
Tajos Investments Private Limited	12,53,500	12.07	12.07
Nandi Synthetics Private Limited	9,19,354	8.85	8.86
Chandra Rameshwar Laddha	1000	0.01	0.01
Mukund Gattani	500	0.01	0.01
Vijay Daulal Damani	361	0	0
Bhagyalakshmi	200	0	0
Chikkanayakanahalli Muddulingaiah Gurumurthy	200	0	0
Deepak Kabra	Nil	Nil	Nil
B Sampathlal	Nil	Nil	Nil
TOTAL	53,01,248	51.04	51.04

Regulatory Compliance

The filing confirms that voting rights other than by shares, warrants, convertible securities, and any other instruments entitling the holder to receive shares were nil. The disclosure was signed by Sunil L Mundra, Promoter and Managing Director, and Pranjal Deshmukh, Company Secretary and Compliance Officer. The document was submitted to the exchanges on April 07, 2026.